Statutory Profit Doesn’t Reflect How Good GSK’s (LON:GSK) Earnings Are

Simply Wall St

Thu, February 12, 2026 at 2:30 PM GMT+9 2 min read

In this article:

GSK

-0.56%

GLAXF

+3.79%

GSK plc’s (LON:GSK) strong earnings report was rewarded with a positive stock price move. We did some digging and found some further encouraging factors that investors will like.

Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit.

LSE:GSK Earnings and Revenue History February 12th 2026

The Impact Of Unusual Items On Profit

Importantly, our data indicates that GSK’s profit was reduced by UK£1.5b, due to unusual items, over the last year. It’s never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that’s exactly what the accounting terminology implies. If GSK doesn’t see those unusual expenses repeat, then all else being equal we’d expect its profit to increase over the coming year.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On GSK’s Profit Performance

Because unusual items detracted from GSK’s earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think GSK’s earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. Of course, we’ve only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it’s equally important to consider the risks facing GSK at this point in time. You’d be interested to know, that we found 2 warning signs for GSK and you’ll want to know about these.

Today we’ve zoomed in on a single data point to better understand the nature of GSK’s profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Have feedback on this article? Concerned about the content? Get in touch** with us directly.**_ Alternatively, email editorial-team (at) simplywallst.com._

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Terms and Privacy Policy

Privacy Dashboard

More Info